Hot on the heels of a $28 million funding round, Durham’s Innocrin Pharma gets FDA fast-track approval for its prostate cancer drug candidate.
Billion-dollar deals, expansions, relocations, acquisitions, venture capital funding, an IPO, government grants, global ccolades, a new pharmacy school and even two Nobel Prizes.
Durham-based Zoion Pharma signs a deal giving France’s Ceva Sante Animale global rights to develop and sell its dry-eye treatment for dogs.
Renowned UNC gene therapy pioneer Jude Samulski receives kudos from Pope Francis for Bamboo Therapeutics’ plans to battle deadly childhood diseases.
Duke University researcher Paul Modrich, and Aziz Sancar of the University of North Carolina at Chapel Hill, are the newest actively working Nobel Laureates in North Carolina.
$73 B in economic activity. 228,000 jobs. 30.9 percent job growth. 4X the national average. However you measure growth, our life science industry has it. Read more in this report from Battelle.
SUBSCRIBE to our newsletters
BOOK A MEETING at the
Hamner Conference Center
tel: 919.541.9366 fax: 919.990.9544 email@example.com
15 TW Alexander Drive Post Office Box 13547 Research Triangle Park, NC 27709-3547